Product Information
NORTREL 7-7-7-28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2346 per EA under NDC 00555901258. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 30, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555901258
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075478FDA Approved
8/30/2002
TE Code
AB
On Market Since
1/2/2003
Price Statistics
The NADAC for NORTREL 7-7-7-28 TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 63.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2346 per EA |
|---|---|
| All-time high | $0.6865 (Apr 13, 2016) |
| All-time low | $0.1916 (Nov 20, 2024) |
| 52-week high | $0.2985 |
| 52-week low | $0.2346 |
| Median price | $0.4533 |
| Average price | $0.4481 |
| Largest weekly change | -36.8% (May 17, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORTREL 7-7-7-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORTREL 7-7-7-28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2346 per EA (NDC 00555901258), effective Aug 19, 2026.
How has the price of NORTREL 7-7-7-28 TABLET changed over time?
Over the history we have for it, the NADAC for NORTREL 7-7-7-28 TABLET has declined 63.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORTREL 7-7-7-28 TABLET?
Since Nov 28, 2013, the NADAC for NORTREL 7-7-7-28 TABLET has ranged from a low of $0.1916 (Nov 20, 2024) to a high of $0.6865 (Apr 13, 2016), with a median of $0.4533 per EA.
Are there cheaper alternatives to NORTREL 7-7-7-28 TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYLIA 1-35 28 TABLET, is $0.2116 per EA — about 10% below NORTREL 7-7-7-28 TABLET.
Who manufactures NORTREL 7-7-7-28 TABLET?
NORTREL 7-7-7-28 TABLET (NDC 00555901258) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.